Back to trial details

Intake questionnaire

A Study of Sacituzumab Govitecan Given at an Alternative Dose and Schedule in Participants With Advanced Triple-Negative Breast Cancer

Applying to Winship Cancer Institute - Emory University · Atlanta, Georgia

Answer a few short questions to share with the research team.

0 of 3 answered

1. Are you 18 years old or older?
2. Have you been diagnosed with Triple Negative Breast Cancer?
3. Are you able to travel to Atlanta for study visits?